Search EN menu en EIB GROUP CLIENT PORTAL
Close EIB GROUP CLIENT PORTAL
Search
Search
Results
Top 5 search results See all results Advanced search
Top searches
    Most visited pages

        TECHEU VD TENSIVE (BIOTECH ACT)

        Summary sheet

        Release date
        1 April 2026
        Reference
        20260015
        Project name
        Promoter - financial intermediary
        TECHEU VD TENSIVE (BIOTECH ACT)
        TENSIVE SRL
        Proposed EIB finance (Approximate amount)
        Total cost (Approximate amount)
        EUR 20 million
        EUR 44 million
        Location
        Sector(s)
        Description
        Objectives

        The project concerns the promoter's research and development activities and CAPEX expenditures to advance regenerative implants for reconstructive surgery and for tissue marking following lumpectomy or mastectomy in breast cancer patients.

        The project focuses on the development, clinical validation, and regulatory approval of REGENERA/SOFTAG, an innovative bioresorbable implant and precision tissue marker designed to support tissue regeneration following lumpectomy (i.e., partial breast removal after breast cancer). In parallel, the associated R&D investments also encompass clinical research into a novel post-mastectomy indication (i.e., full breast removal after breast cancer), leveraging advanced biomaterial 3D printing technology to enable the development of next-generation reconstructive implants.

        Environmental aspects
        Procurement

        The project would not require an Environmental Impact Assessment (EIA) under Directive 2014/52/EU amending the Directive 2011/92/EC as research, development and innovation activities will be carried out in facilities already authorised for the same purpose. Full environmental details will nevertheless be verified to align with EU best practices.

        The EIB requires that all project contracts are procured in accordance with the applicable EU procurement legislation.

        Related projects
        Parent project
        TECHEU THEMATIC INNOVATION (INVESTEU VD) LE II

        Disclaimer

        Before financing approval by the Board of Directors, and before loan signature, projects are under appraisal and negotiation. The information and data provided on this page are therefore indicative.
        They are provided for transparency purposes only and cannot be considered to represent official EIB policy (see also the Explanatory notes).

        General enquiries and comments

        The EIB is committed to open communication and encourages constructive stakeholder input regarding its activities.
        Enquiries and comments concerning the EIB’s involvement in a project or the financing facilities, activities, organisation and objectives of the EIB, can be sent to the EIB Infodesk.
        Alternatively, the EIB can be contacted through its external offices.
        Queries regarding details of a specific project, in particular when it is under appraisal by the EIB, should preferably be addressed directly to project promoters.

        Media enquiries

        Media-related enquiries can be addressed to the EIB Press Office. Please also visit our Media information section.

        Complaints mechanism

        Any complaint regarding alleged maladministration can be lodged via the EIB Complaints Mechanism. The European Ombudsman acts as an independent external accountability mechanism of the EIB.

        Zero tolerance against fraud and corruption

        The EIB has a zero tolerance policy on fraud or corruption. To report allegations of fraud and corruption relating to EIB-financed projects, please contact the Investigations Division. All reports will be treated as strictly confidential and handled in line with EIB investigation procedures and the EIB Group Anti-Fraud Policy.

        Related publications